Literature DB >> 16911625

The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.

N C Pegge1, A M Twomey, K Vaughton, M B Gravenor, M W Ramsey, D E Price.   

Abstract

BACKGROUND: Erectile dysfunction (ED) in diabetes is related to autonomic neuropathy and endothelial dysfunction. We studied the relative importance of these factors in diabetic and non-diabetic men with ED and determined if they predict responses to treatment with sildenafil.
METHODS: Thirty-three men, aged 35-65 years, with ED (20 diabetic, 13 non-diabetic), 15 of whom were sildenafil responders and 18 non-responders, were compared with 30 age and risk-matched control subjects (15 diabetic, 15 non-diabetic). Subjects with ED completed the International Index of Erectile Function (IIEF) questionnaire. Endothelial function was assessed by changes in brachio-radial and femoro-tibial arterial pulse-wave velocity (pulse-wave velocity) during reactive hyperaemia, expressed as percentage endothelium-dependent dilatation. Autonomic function was assessed by heart rate variation during expiration and inspiration (E/I ratio) and during the valsalva manoeuvre.
RESULTS: The respective changes in pulse-wave velocity, in the arm and leg [mean (sd)] were 0.71 (6.5)% and 3.5 (6.4)% in the impotent diabetic men, 0.7 (7.6)% and 2.4 (5.9)% in the non-diabetic impotent men, -0.68 (5.7)% and -1.31 (7.2)% in the non-impotent diabetic men and 7.7 (3.7)% and 7.6 (3.4)% in the control subjects. There was a significant interaction between ED and diabetic status such that there was significantly impaired vascular response in the diabetic group (both with and without ED) and in the non-diabetic group with ED compared with the non-diabetic control group (P = 0.01 and P = 0.001 for brachio-radial and femoro-tibial measures, respectively). The E/I ratios of the diabetic men were significantly lower than those of the control subjects [1.17 (0.14) vs. 1.33 (0.16), P < 0.02), but there were no differences in the measures of autonomic neuropathy between the groups with ED and those with normal erectile function. Amongst diabetic men, the initial IIEF scores (maximum score 30, low score indicates more severe ED) were significantly higher in sildenafil-responders than non-responders [16.3 (8.4), vs. 6.8 (7 1), P < 0.02]. The rate of sildenafil response was not significantly affected by the measures of endothelial or autonomic function.
CONCLUSIONS: ED in both diabetic and non-diabetic men is characterized by marked endothelial dysfunction in comparison with non-diabetic control subjects. Response to sildenafil is not predicted by either endothelial function or autonomic function, but in diabetic men appears to be related to the initial degree of erectile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911625     DOI: 10.1111/j.1464-5491.2006.01911.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

Review 1.  The role of vitamin D supplementation on erectile function.

Authors:  Raidh A Talib; Kareim Khalafalla; Önder Cangüven
Journal:  Turk J Urol       Date:  2017-04-18

2.  The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model.

Authors:  Yun-Ching Huang; Hongxiu Ning; Alan W Shindel; Thomas M Fandel; Guiting Lin; Ahmed M Harraz; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2010-02-05       Impact factor: 3.802

3.  Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Marco Natali; Andrea Lenzi
Journal:  Ther Adv Urol       Date:  2009-10

Review 4.  Management of erectile dysfunction in diabetes: an update for 2008.

Authors:  David Price; Geoffrey Hackett
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

5.  Erectile dysfunction and its management in patients with diabetes mellitus.

Authors:  Giuseppe Defeudis; Daniele Gianfrilli; Chiara Di Emidio; Riccardo Pofi; Dario Tuccinardi; Andrea Palermo; Andrea Lenzi; Paolo Pozzilli
Journal:  Rev Endocr Metab Disord       Date:  2015-10-26       Impact factor: 6.514

6.  Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.

Authors:  A Schäfer; D Fraccarollo; S Pförtsch; U Flierl; C Vogt; J Pfrang; A Kobsar; T Renné; M Eigenthaler; G Ertl; J Bauersachs
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

7.  Improvement of erectile function by Korean red ginseng (Panax ginseng) in a male rat model of metabolic syndrome.

Authors:  Sung-Dae Kim; Young-Joo Kim; Jung-Sik Huh; Sae-Woong Kim; Dong-Wan Sohn
Journal:  Asian J Androl       Date:  2013-02-04       Impact factor: 3.285

Review 8.  Urogenital Autonomic Dysfunction in Diabetes.

Authors:  Barbara H Braffett; Hunter Wessells; Aruna V Sarma
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 5.430

9.  Time-dependent changes of erectile function in diabetic rats: role of systemic endothelial dysfunction.

Authors:  Woo Suk Choi; Kwanjin Park; Jae-Seung Paick; Soo Woong Kim
Journal:  World J Mens Health       Date:  2012-08-31       Impact factor: 5.400

10.  Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and Diabetes.

Authors:  Jung Woo Lee; Hyun Jun Park; Nam Cheol Park
Journal:  Korean J Urol       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.